Page 32 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Daventry Group LP acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 63,123 shares of the medical research company’s stock, valued at approximately $12,739,000. Charles […]

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) Director Richard F. Wallman bought 1,000 shares of Charles River Laboratories International stock in a transaction dated Thursday, August 24th. The shares were bought at an average cost of $198.79 per share, with a total value of $198,790.00. Following the completion of the transaction, the […]

WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", "We", "Our" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug

WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced the completion of the sale of its businesses in Israel. The sale complements Inotiv’s site optimization plan for the Research Models and Services segment of the business. The Comp

WEST LAFAYETTE, Ind., Aug. 29, 2023 -- Inotiv, Inc. , a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research...